在接受心血管外科手术的患者中,胺酸对脏结果的影响:符合系统性审查和元分析的系统性审查和元分析的首选报告项的系统性审查和元分析
Bo Zhang1, Li-Xian He2, Yun-Tai Yao3
1Department of Anesthesiology, Tianjin Union Medical Center, Tianjin, China.
Journal of cardiothoracic and vascular anesthesia
|December 4, 2025
概括
特兰胺酸 (TXA) 似乎不会影响接受心血管手术的患者的结局. 这次系统性审查发现TXA和安慰剂组之间急性损伤率或其他标记物没有显著差异.
科学领域:
- 心血管外科心血管外科
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 心血管外科手术带有术前脏损伤的风险.
- 特兰胺酸 (TXA) 用于减少出血,但其对脏的影响仍有争议.
研究的目的:
- 评估特兰胺酸 (TXA) 对接受心血管手术的患者结局的影响.
- 综合随机对照试验 (RCT) 对TXA对急性损伤 (AKI) 和其他标记物的影响的证据.
主要方法:
- 19个RCT的系统审查和元分析.
- 包括6,450名心血管外科手术患者 (3,280名TXA,3,170名安慰剂).
- 评估了术后的AKI,血清肌素,血液尿素,尿液产量和死亡率.
主要成果:
- TXA没有显著影响术后AKI的发生率 (4.2%对4.3%;OR,0.96).
- 手术后血清肌和血尿素水平在TXA和安慰剂组之间是可比的.
- TXA没有影响30天死亡率 (1.1%对1.6%;OR,0.71).
结论:
- 在心血管外科手术患者中,胺酸的使用似乎不会改变的结果.
- 目前的证据表明,TXA对这一群体的功能是安全的.
- 进一步的研究可能会探索特定的子组或替代性保护策略.
相关概念视频
Venous Thrombosis III: Interprofessional Care
265
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
265
Aneurysm IV: Nursing Management
359
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
359
Cardiac Catheterization I: Pre-Procedure Overview
997
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
997


